New York Office
Allen is a Managing Director at Torreya Partners and a member of our Generic Pharma Advisory team. He joined the firm with more than 20 years of operating and business development experience. Previously, he spent 19 years at Teva in corporate, generics, and API most recently serving as global CFO of Commercial Operations for Teva API after holding the same role at Teva API North America for 3 years. He subsequently served Sandoz as the U.S. Head of Business Development. Allen is currently active in a variety of transaction projects involving generic and OTC opportunities.